News | OneThree Biotech

OneThree Biotech and Poolbeg Pharma Partner to Identify New Drug Targets for RSV

OneThree Biotech Partners With Poolbeg Pharma to Identify New Drug Targets and Treatments for Respiratory Syncytial Virus (‘RSV’) https://polaris.brighterir.com/public/poolbeg_pharma/news/rns/story/xqo332r

Is AI Delivering on the Hype? – Commentary From OneThree Biotech

OneThree Biotech Joins Forces with SPARC to Characterize a Key Oncologic Pathway https://www.biospace.com/article/releases/onethree-biotech-joins-forces-with-sparc-to-characterize-a-key-oncologic-pathway/

OneThree Biotech Joins Forces with SPARC to Characterize a Key Oncologic Pathway

OneThree won Reuters Entrepreneur Award: Healthcare Solution

Jubilant Therapeutics, OneThree Biotech ID Biomarkers for LSD1, HDAC6 Inhibitor

Jubilant Therapeutics, OneThree Biotech ID Biomarkers for LSD1, HDAC6 Inhibitor https://www.precisiononcologynews.com/cancer/jubilant-therapeutics-onethree-biotech-id-biomarkers-lsd1-hdac6-inhibitor#.Ya6LDC9abyV

OneThree selected as a finalist for two Reuters Entrepreneur Awards

OneThree Biotech Raises Seed Round For AI-Driven Drug Platform

OneThree Biotech Raises Seed Round For AI-Driven Drug Platform https://news.crunchbase.com/news/onethree-biotech-raises-seed-round-for-ai-driven-drug-platform/

Al Algorithm Predicts Drug Targets, Leads to Promising Results for Experimental Cancer Treatment

Al Algorithm Predicts Drug Targets, Leads to Promising Results for Experimental Cancer Treatment https://news.weill.cornell.edu/news/2020/01/al-algorithm-predicts-drug-targets-leads-to-promising-results-for-experimental-cancer

Running the Numbers

Running the Numbers https://news.weill.cornell.edu/news/2017/05/running-the-numbers

Toxic targets: Saving lives in silico

Toxic targets: Saving lives in silico https://meyercancer.weill.cornell.edu/news/2017-04-01/toxic-targets-saving-lives-silico